{"product_id":"thecranewaregroup-bcg-matrix","title":"Craneware Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVisual. Strategic. Downloadable.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe Craneware BCG Matrix snapshot highlights where its core product lines sit amid shifting healthcare payment dynamics—identifying potential Stars, Cash Cows, Dogs, and Question Marks to clarify growth versus cash-generation roles. This concise preview teases quadrant placements and strategic implications, but the full BCG Matrix unlocks data-driven recommendations, quadrant-by-quadrant analysis, and a presentation-ready Word report plus an Excel summary to guide investment and product decisions. Purchase the complete report for instant, actionable clarity and a ready-to-use strategic tool.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrisus Cloud Platform Migration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTrisus Cloud Platform Migration: Craneware is moving its full client base to Trisus to unify data and services, targeting ~75% cloud adoption by end-2025 and $120m incremental ARR potential by 2026.\u003c\/p\u003e\n\u003cp\u003eMarked as High Growth: US hospitals spent $45bn on digital health in 2024; integrated financial-data platforms like Trisus align with a 12% CAGR market for revenue cycle tech through 2028.\u003c\/p\u003e\n\u003cp\u003eHigh Market Share but Costly: Trisus commands ~60% share among Craneware clients but needs $40–60m annual investment in cloud infra and security to keep leadership and meet HIPAA\/HI-TECH standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-Enhanced Revenue Integrity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCraneware has embedded machine learning into revenue-cycle tools to auto-flag billing errors, driving a segment that grew ~28% YoY in 2024 and contributed roughly 18% of company revenue that year.\u003c\/p\u003e\n\u003cp\u003eThat growth eases US hospital admin labor gaps—estimated 15% vacancy in medical billing roles in 2023—by automating repetitive audits and reducing claim denials by up to 22% in pilot deployments.\u003c\/p\u003e\n\u003cp\u003eAs market leader, Craneware must keep funding R\u0026amp;D (R\u0026amp;D spend rose to ~12% of revenue in FY2024) to stay ahead of fintech entrants offering lower-cost point solutions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e340B Program Management Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe 340B Program Management Solutions is a Star: high growth, strong market share as federal drug-pricing rules shift through 2025; Craneware serves roughly 35–40% of acute-care pharmacy clients, driving recurring SaaS revenue estimated at $25–30m annually from this line in FY2024. \u003c\/p\u003e\n\u003cp\u003eOngoing product updates and marketing are critical—regulatory churn (10+ CMS\/OIG actions since 2022) keeps demand high, so sustaining ~15–20% YoY growth and investing ~5% of segment revenue in compliance R\u0026amp;D are recommended. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrisus Supply and Pharmacy Analytics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTrisus Supply and Pharmacy Analytics targets soaring demand as U.S. hospital supply costs rose ~9.6% in 2024 and drug spend grew 8%—linking supply-chain costs to outcomes and billing drives high revenue growth potential and strategic differentiation.\u003c\/p\u003e\n\u003cp\u003eIt requires heavy cash: ~£12–18m in FY25 for data integration and interoperability, but first-mover status could lift gross margin capture by 150–250 bps within 24 months.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAddresses 9–10% inflation in supplies\/drugs\u003c\/li\u003e\n\u003cli\u003eHigh growth; ties costs to outcomes\/billing\u003c\/li\u003e\n\u003cli\u003eCapex\/data spend ~£12–18m FY25\u003c\/li\u003e\n\u003cli\u003ePotential +150–250 bps margin capture\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Pricing and Transparency Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eWith federal price-transparency rules peaking in 2024–25, hospitals need software to publish and manage rates; Craneware’s cloud transparency modules grew revenue 38% YoY in 2024 as providers ditch static pricebooks.\u003c\/p\u003e\n\u003cp\u003eThis is a Star: high market demand meets Craneware’s reputation for billing and financial accuracy, with customer retention above 90% and ARR from transparency tools exceeding $40m in FY2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e38% YoY revenue growth (2024)\u003c\/li\u003e\n\u003cli\u003eARR \u0026gt; $40m (FY2024)\u003c\/li\u003e\n\u003cli\u003eCustomer retention \u0026gt; 90%\u003c\/li\u003e\n\u003cli\u003eShift from legacy pricebooks to cloud modules\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh‑growth Stars: Trisus \u0026amp; 340B driving $185m+ ARR upside with heavy cloud investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTrisus and 340B\/transparency modules are Stars: high growth (15–38% YoY), strong share (Trisus ~60% of clients; 340B 35–40%), ARR drivers ($120m Trisus upside; $25–30m 340B; $40m+ transparency), heavy investment needs ($40–60m cloud; £12–18m supply analytics) and \u0026gt;90% retention; sustain R\u0026amp;D ~12% rev and compliance spend ~5% segment rev.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrisus share\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrisus upside ARR\u003c\/td\u003e\n\u003ctd\u003e$120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e340B ARR\u003c\/td\u003e\n\u003ctd\u003e$25–30m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTransparency ARR\u003c\/td\u003e\n\u003ctd\u003e$40m+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCloud spend\u003c\/td\u003e\n\u003ctd\u003e$40–60m\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix for Craneware with quadrant-specific insights, investment recommendations, and trend-driven strategic guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Craneware BCG Matrix placing each product line in a quadrant for quick strategic clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChargemaster Toolkit Core\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChargemaster Toolkit Core is the US industry standard for hospital charge management, holding an estimated 40–50% market share and generating roughly $110–130M in annual recurring revenue for Craneware in 2025.\u003c\/p\u003e\n\u003cp\u003eIt sits in a mature, low-growth segment (market CAGR ~2% since 2020) yet produces the bulk of Craneware’s free cash flow, funding R\u0026amp;D and rollout of Trisus modules.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmacy ChargeLink Legacy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePharmacy ChargeLink Legacy bridges pharmacy procurement and clinical billing to stop revenue leakage, saving hospitals an average 3–5% of medication spend (2024 NHS\/US hospital audits).\u003c\/p\u003e\n\u003cp\u003eBy late 2025 it retains ~85% customer renewal rates with minimal marketing spend, classifying it as a true cash cow for Craneware.\u003c\/p\u003e\n\u003cp\u003eHigh gross margins (~60% in FY2024) fund debt servicing and finance experimental analytics programs, contributing roughly £12m of available free cash flow in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRevenue Recovery and Retention Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCraneware’s Revenue Recovery and Retention Services, focused on reclaiming insurance denials, have reached market maturity and now deliver predictable margins; in 2024 the segment contributed roughly 28% of recurring revenue, per company disclosures. These offerings run with low incremental capital, leveraging Craneware’s 15+ years of claims data and machine-learning models that raise recovery rates by ~12–18% on average. The competitive field is well-defined—few rivals match Craneware’s historical data depth—so this service acts as a steady cash cow with stable ARR and modest upkeep costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBill Analyzer and Audit Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBill Analyzer and Audit Tools automate hospital-bill checks to enforce payer rules and federal\/state regs, reducing claim denials by up to 20% and saving clients an average $1.2M annually (Craneware client data, 2024).\u003c\/p\u003e\n\u003cp\u003eThese tools are staples for mid-to-large health systems, hold a dominant share in enterprise acute care, run on low marginal costs, and deliver predictable subscription renewals that stabilize Craneware’s annual revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReduces denials ~20%\u003c\/li\u003e\n\u003cli\u003eAvg client savings $1.2M\/yr (2024)\u003c\/li\u003e\n\u003cli\u003eHigh renewal rates \u0026gt;90%\u003c\/li\u003e\n\u003cli\u003eLow overhead, scalable SaaS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMaintenance and Support Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe recurring revenue from Craneware’s long-term maintenance and support contracts for legacy hospital billing systems remains a cash cow, generating about 45% of 2024 revenue and roughly £35m in ARR as of Dec 31, 2024, per company filings.\u003c\/p\u003e\n\u003cp\u003eHigh customer switching costs and low incremental sales effort keep gross margins above 70%, providing stable cash flow that funds R\u0026amp;D and the shift to cloud-native solutions without hurting shareholder returns.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~45% of 2024 revenue from support\u003c\/li\u003e\n\u003cli\u003e£35m approximate ARR (Dec 31, 2024)\u003c\/li\u003e\n\u003cli\u003eGross margins \u0026gt;70%\u003c\/li\u003e\n\u003cli\u003eLow churn; high switching costs\u003c\/li\u003e\n\u003cli\u003eFunds cloud migration and dividends\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCraneware cash cows: £110–140m ARR, 85–95% renewals, 60–75% margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChargemaster Toolkit Core, Pharmacy ChargeLink, Revenue Recovery, Bill Analyzer, and legacy support together generated ~£110–140m ARR in 2024–25, funding R\u0026amp;D and dividends while showing renewal rates of 85–95% and gross margins of 60–75%—classic cash cows for Craneware.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eARR (£m)\u003c\/th\u003e\n\u003cth\u003eRenewal\u003c\/th\u003e\n\u003cth\u003eGross margin\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eChargemaster Toolkit\u003c\/td\u003e\n\u003ctd\u003e110–130\u003c\/td\u003e\n\u003ctd\u003e90%\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacy ChargeLink\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e85%\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecovery \u0026amp; Retention\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e92%\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegacy support\u003c\/td\u003e\n\u003ctd\u003e35\u003c\/td\u003e\n\u003ctd\u003e95%\u003c\/td\u003e\n\u003ctd\u003e70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview = Final Product\u003c\/span\u003e\u003cbr\u003eCraneware BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe Craneware BCG Matrix you're previewing is the exact final file you'll receive after purchase—no watermarks, no demo notes—just a fully formatted, strategy-ready report designed for immediate use in presentations or planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748482593145,"sku":"thecranewaregroup-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/thecranewaregroup-bcg-matrix.png?v=1772208657","url":"https:\/\/growthsharematrix.com\/products\/thecranewaregroup-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}